- Twenty minutes twice a week may slow dementia progression.
- The study is from Texas A&M University researchers.
- Researchers used national data from 2012 to 2020.
- They tested memory recall and simple thinking tasks.
- The study included 9,714 older adults in total.
- People with moderate activity had less decline.
- Walking and playing sports were common activities studied.
- The researchers say the results may guide new programs.
- The study has some limits to consider.
Difficult words
- dementia — a brain disease that affects memory and thinking
- progression — the process of getting worse over time
- researcher — a person who studies and tests factsresearchers
- recall — to remember information from memory
- moderate — not low and not high; a medium level
- decline — a decrease in ability or condition
- activity — something you do for movement or exerciseactivities
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you walk or play sports?
- How many minutes do you exercise each week?
- Would you join a new program for older adults?
Related articles
Low pesticide exposure speeds aging in fish
Researchers found that long-term exposure to low levels of a common agricultural insecticide caused faster physiological aging and shorter lifespans in wild and laboratory fish. The study links telomere shortening and lipofuscin buildup to chlorpyrifos exposure.
Simpler treatment trial for cryptococcal meningitis in Malawi
Cryptococcal meningitis kills many people in Sub‑Saharan Africa and mainly affects people with HIV. A Phase II trial in Lilongwe is testing a sustained‑release flucytosine pellet to make treatment easier, while clinicians warn that early testing and care remain vital.
Cell transplant may help heart after spinal cord injury
Researchers tested transplanting immature nerve cells into spinal cord injuries in rats. The transplants improved nerve control of circulation — stabilizing resting blood pressure and lowering heart rate — but hormonal responses after injury still rose.
Personalized DNA vaccine shows promise against glioblastoma
A phase 1 trial found the personalized DNA vaccine GNOS-PV01 is safe and shows early signs of activity against glioblastoma. The small study at Siteman Cancer Center and WashU Medicine reported immune responses and encouraging clinical outcomes.